Anika Therapeutics, Inc.
ANIK
$14.36
$0.161.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 58.89% | 51.13% | 58.60% | 65.08% | 67.98% |
| Total Depreciation and Amortization | 0.45% | 660.63% | 69.95% | 26.53% | 0.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -51.76% | -56.31% | -62.88% | -64.14% | -58.99% |
| Change in Net Operating Assets | 94.36% | 86.14% | 43.25% | 37.00% | -20.30% |
| Cash from Operations | 107.07% | 9.04% | -29.67% | 216.84% | 402.18% |
| Capital Expenditure | -4.73% | -6.16% | 28.16% | -28.87% | -20.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 95.19% | 78.50% | 74.46% | 16.97% | -53.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -36.22% | -32.12% | -32.12% | -9.83% | -5.31% |
| Repurchase of Common Stock | -16.06% | -189.44% | -181.10% | -61.78% | -33.14% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 17.11% | -51.09% | -363.32% | -127.58% | -101.28% |
| Foreign Exchange rate Adjustments | 122.34% | 111.73% | 238.63% | -1,466.67% | -587.34% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 102.05% | 47.14% | -329.30% | -37.36% | -16.70% |